Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 4/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34204 | 0.97 | — | — | |
| SCHEMBL8052335 | 0.97 | — | — | |
| SCHEMBL6935442 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL7540787 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL31378077 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL23243497 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL237772 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR | |
| Bromide SCHEMBL8601246 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL9217677 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR | |
| Hydrochloric Acid SCHEMBL11572374 | 0.93 | TDP1 (0.50) | TDP1CYP3A4ESR1ESR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1205494-B1 | Catalyst component and catalyst for addition polymerization, and process for producing addition polymers | SUMITOMO CHEMICAL CO (JP) | 2008-04-09 | — | — | EP | disclosed |
| US-6723807-B2 | CYCLOPENTADIENE METAL COMPLEX WITH NITROGEN AND AN ORGANOALUMINUM, AND AN ALUMINOXANE AND/OR BORON COMPOUND; HIGH ACTIVITY. | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20030158355-A1 | Catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-08-21 | — | — | US | disclosed |
| US-20020091209-A1 | Catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-07-11 | — | — | US | disclosed |
| EP-1205494-A1 | Catalyst component and catalyst for addition polymerization, and process for producing addition polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091209-A1 | Catalyst component and catalyst for addition polymerization, and process for producing addition polymer | ZYX, MLX, AP1M1 | TDP1 4637/4885CYP3A4 2946/4885ESR1 4071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.